SS Innovations Achieves 10,500 Surgeries with SSi Mantra Robotic System, Expanding Global Access to Affordable Robotic Surgery

SS Innovations International, Inc. (Nasdaq: SSII) announced today that its SSi Mantra surgical robotic system has been used to perform more than 10,500 cumulative surgeries as of April 30, 2026. The milestone underscores the company’s progress in making robotic surgery affordable and accessible globally. The procedures include over 500 cardiac surgeries, 170 telesurgeries, and 125 pediatric operations, utilizing more than 170 different types of procedures across multiple specialties.

The SSi Mantra, which received commercial launch in August 2022, has established a strong presence in India and expanded to over 200 systems installed across eleven countries. Approximately 2,100 physicians have been trained on the system. Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, credited the achievement to the system’s advanced technology, ease of training, user-friendliness, and cost advantages. “Together, we are helping democratize access to world-class surgical robotic care,” he stated.

The company’s focus on affordability and accessibility addresses a critical gap in global healthcare. Traditional robotic surgery systems are often prohibitively expensive, limiting their use to wealthier institutions and countries. SS Innovations aims to change that by offering a modular, multi-arm system with features such as an open-faced ergonomic surgeon console, 3D 4K visualization, and telesurgery capabilities through the optional SSi MantrAsana Tele Surgeon Console. The system supports over 40 types of robotic instruments, including 5mm instruments for pediatric and ENT surgeries.

The implications of this milestone are significant for the broader adoption of robotic surgery. By demonstrating high volumes of diverse procedures and training a large number of surgeons, SS Innovations is building evidence that the SSi Mantra can be effectively deployed in various healthcare settings. The inclusion of telesurgeries points to potential for remote surgical expertise, which could be transformative for underserved regions. For more details, visit the company’s newsroom at SS Innovations Newsroom.

SS Innovations, headquartered in India but incorporated in the U.S., continues to expand its global footprint. The company’s product line includes the SSi Mantra system and the SSi Mudra surgical instruments, designed to support a variety of procedures including cardiac surgery. The latest data reinforces the system’s clinical validation in over 100 different surgical types in India, positioning it as a viable competitor to established robotic platforms. As the installed base grows, the company’s ability to maintain training quality and outcomes will be key to sustaining momentum.

With more than 10,500 surgeries completed in under four years since commercial launch, SS Innovations is demonstrating that its strategy of combining advanced technology with cost-effectiveness can drive rapid adoption. The company’s mission to make robotic surgery affordable and accessible may have far-reaching effects on surgical care delivery worldwide, particularly in emerging economies where such technology has been scarce.

This news story relied on content distributed by PRISM Mediawire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is SS Innovations Achieves 10,500 Surgeries with SSi Mantra Robotic System, Expanding Global Access to Affordable Robotic Surgery.

The post SS Innovations Achieves 10,500 Surgeries with SSi Mantra Robotic System, Expanding Global Access to Affordable Robotic Surgery appeared first on citybuzz.